These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

688 related items for PubMed ID: 18670270

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Cytoreductive nephrectomy in metastatic renal cell carcinoma: the evolving role of surgery in the era of molecular targeted therapy.
    Kwan KG, Kapoor A.
    Curr Opin Support Palliat Care; 2009 Sep; 3(3):157-65. PubMed ID: 19528804
    [Abstract] [Full Text] [Related]

  • 3. Cytoreductive nephrectomy for metastatic renal cell carcinoma: is it still imperative in the era of targeted therapy?
    Pantuck AJ, Belldegrun AS, Figlin RA.
    Clin Cancer Res; 2007 Jan 15; 13(2 Pt 2):693s-696s. PubMed ID: 17255295
    [Abstract] [Full Text] [Related]

  • 4. Role of cytoreductive nephrectomy in renal cell carcinoma.
    Chiong E, Wood CG, Margulis V.
    Future Oncol; 2009 Aug 15; 5(6):859-69. PubMed ID: 19663735
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The role of nephron sparing surgery for metastatic (pM1) renal cell carcinoma.
    Krambeck AE, Leibovich BC, Lohse CM, Kwon ED, Zincke H, Blute ML.
    J Urol; 2006 Nov 15; 176(5):1990-5; discussion 1995. PubMed ID: 17070231
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Treatment of patients with metastatic renal cell cancer: a RAND Appropriateness Panel.
    Halbert RJ, Figlin RA, Atkins MB, Bernal M, Hutson TE, Uzzo RG, Bukowski RM, Khan KD, Wood CG, Dubois RW.
    Cancer; 2006 Nov 15; 107(10):2375-83. PubMed ID: 17048248
    [Abstract] [Full Text] [Related]

  • 12. Laparoscopic versus open cytoreductive nephrectomy for metastatic renal cell carcinoma.
    Rabets JC, Kaouk J, Fergany A, Finelli A, Gill IS, Novick AC.
    Urology; 2004 Nov 15; 64(5):930-4. PubMed ID: 15533480
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Expanding the indications for surgery and adjuvant interleukin-2-based immunotherapy in patients with advanced renal cell carcinoma.
    Belldegrun A, Shvarts O, Figlin RA.
    Cancer J Sci Am; 2000 Feb 15; 6 Suppl 1():S88-92. PubMed ID: 10685666
    [Abstract] [Full Text] [Related]

  • 15. Cytoreductive nephrectomy for T4NxM1 renal cell carcinoma: the M.D. Anderson Cancer Center experience.
    Kassouf W, Sanchez-Ortiz R, Tamboli P, Jonasch E, Merchant MM, Spiess PE, Wood CG.
    Urology; 2007 May 15; 69(5):835-8. PubMed ID: 17482917
    [Abstract] [Full Text] [Related]

  • 16. Debulking nephrectomy in metastatic renal cancer.
    Flanigan RC.
    Clin Cancer Res; 2004 Sep 15; 10(18 Pt 2):6335S-41S. PubMed ID: 15448027
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Laparoscopic cytoreductive nephrectomy for metastatic renal cell carcinoma.
    Finelli A, Kaouk JH, Fergany AF, Abreu SC, Novick AC, Gill IS.
    BJU Int; 2004 Aug 15; 94(3):291-4. PubMed ID: 15291853
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.